comparemela.com

Latest Breaking News On - Sato pharmaceuticals - Page 1 : comparemela.com

Demand for nasal antihistamines in North America is projected to rise at a 3 1% CAGR through 2031 |

According to a recent study by Future Market Insights (FMI), the nasal antihistamines market is expected to witness steady growth during the forecast period. The market valuation is expected to increase from US$ 1.89 Bn in 2020 to over US$ 3.08 Bn by 2031. This reflects a cumulative CAGR of around 3.1% over the fore.

Sales of nasal antihistamines in Japan and South Korea are projected to grow at 5 3% and 3 8% CAGR r

According to a recent study by Future Market Insights (FMI), the nasal antihistamines market is expected to witness steady growth during the forecast period. The market valuation is expected to increase from US$ 1.89 Bn in 2020 to over US$ 3.08 Bn by 2031. This reflects a cumulative CAGR of around 3.1% over the fore.

Novan, Inc (NASDAQ:NOVN) Q4 2022 Earnings Call Transcript

Novan s (NOVN) EPI Health Enter Exclusive License Agreement with Sato for RHOFADE in Japan

Novan s (NOVN) EPI Health Enter Exclusive License Agreement with Sato for RHOFADE in Japan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nasal Antihistamines Market is anticipated to total US$ 3 0 Billion by 2031

According to a recent study by Future Market Insights (FMI), the nasal antihistamines market is expected to witness steady growth during the forecast period. The market valuation is expected to increase from US$ 1.89 Bn in 2020 to over US$ 3.08 Bn by 2031. This reflects a cumulative CAGR of around 3.1% over the fore.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.